CAS 1996636-69-1 appears in our catalog under these names: CT-179, 99.61%, CT-179, 98%. Offered by: MedChemExpress, Ambeed. Available pack sizes: 10 mg, 10mM/1mL, 5 mg, 100 mg, 50 mg, 25 mg, 5mg, 10mg.
CT-179 is a member of the class of pyridines that is pyridine substituted by [(3,4-dichlorophenyl)carbamoyl]amino, [3-(dimethylamino)propyl]amino, and methyl groups at positions 2, 4 and 6, respectively. It is a small molecule inhibitor of OLIG2 developed by Curtana Pharmaceuticals for the treatment of glioblastoma, medulloblastoma, and other brain cancers. It has a role as an OLIG2 inhibitor and an antineoplastic agent. It is a member of phenylureas, a dichlorobenzene, a member of pyridines, a secondary amino compound and a tertiary amino compound.
Source: ChEBI
| Molecular formula | C17H22Cl2N6O |
|---|---|
| Molecular weight | 397.3 g/mol |
| IUPAC name | 1-(3,4-dichlorophenyl)-3-[4-[3-(dimethylamino)propylamino]-6-methylpyrimidin-2-yl]urea |
| InChIKey | MWEZWAONAIZIAQ-UHFFFAOYSA-N |
| SMILES | CC1=CC(=NC(=N1)NC(=O)NC2=CC(=C(C=C2)Cl)Cl)NCCCN(C)C |
Computed by PubChem (NCBI)